Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Rang in Aktien #28133
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Aktienkurs
$0.37430781
Zuletzt synchronisiert: 2026-08-19
Marktkapitalisierung
$28.37M
Veränderung (1 Tag)
2.00%
Veränderung (1 Jahr)
-13.46%
Land
CA
Handel Defence Therapeutics Inc. (DTC)

Kategorie

Aktien-Split-Historie für Defence Therapeutics Inc. (DTC)
Die Aktie Defence Therapeutics Inc. (Symbol: DTC) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 20, 2026 statt.
Eine DTC-Aktie, die vor dem Aug 20, 2026 gekauft wurde, entspricht heute 0 DTC-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH